Palliative sedation involves using sedatives to reduce consciousness until death. Though common in end-of-life care, it remains complex and controversial, with unclear quality parameters and limited guidance for improvement. A comprehensive overview of elements that reflect quality in palliative sedation is currently missing.
Aim:
To identify quality reflecting elements for palliative sedation reported in peer-reviewed, indexed and gray literature.
Design:
Scoping review using Levac et al.’s methodological framework, including systematic searching, screening and narrative synthesis.
Data sources:
Academic databases with indexed sources (MEDLINE, EMBASE, CENTRAL, CINAHL, PsycINFO) and databases also containing gray literature (MEDNAR, Web of Science) were searched between February and December 2023 for sources with primary data published after 2009, without restrictions on population or study design.
Results:
Among the 60 sources analyzed, 157 elements reflecting palliative sedation quality were identified and thematized into 22 themes and four overarching domains: (1) process elements of decision-making such as indication, proximity to death, timing, patient involvement, proactiveness, patient support, family involvement, artificial nutrition and hydration; (2) process elements of performance, such as level of sedation, medication use, monitoring, duration, care continuation, family support; (3) outcome elements covering patient comfort, family well-being, family satisfaction, professionals’ well-being and satisfaction; (4) process elements of collaboration and documentation.
Conclusion:
This scoping review found a broad range of elements reflecting palliative sedation quality – beyond clinical performance, sedation outcomes or patient level elements alone. These insights can inform the development of a core set of indicators to support quality monitoring in palliative sedation.
ChernyNIRadbruchL. The Board of the European Association for Palliative Care. European Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care - Nathan I Cherny, Lukas Radbruch, The Board of the European Association for Palliative Care, The Board of the European Association for Palliative Care. Palliat Med2009; 23(7): 581–593.
2.
RobijnLCohenJRietjensJ, et alTrends in continuous deep sedation until death between 2007 and 2013: a repeated nationwide survey. PLOS ONE2016; 11(6): e0158188.
3.
GarraldaEBusa PozsgaiC, et alRegulations on palliative sedation: an international survey across eight European countries. Eur J Public Health2023; 33(1): 35–41.
4.
TwycrossR. Reflections on palliative sedation. PalliatCare2019; 12: 1178224218823511.
5.
RausKSterckxS. How defining clinical practices may influence their evaluation: the case of continuous sedation at the end of life. J Eval Clin Pract2015; 22: 425–432.
6.
PapavasiliouESBrearleySGSeymourJE, et alFrom sedation to continuous sedation until death: How has the conceptual basis of sedation in End-of-Life care changed over time?J Pain Symptom Manag2013; 46(5): 691–706.
7.
BelarAArantzamendiMMentenJ, et alThe decision-making process for palliative sedation for patients with advanced cancer-analysis from a systematic review of prospective studies. Cancers2022; 14(2): 301.
8.
BruinsmaSMRietjensJASeymourJE, et alThe experiences of relatives with the practice of palliative sedation: a systematic review. J Pain Symptom Manag2012; 44(3): 431–445.
9.
RobijnLSeymourJDeliensL, et alThe involvement of cancer patients in the four stages of decision-making preceding continuous sedation until death: a qualitative study. Palliat Med2018; 32(7): 1198–1207.
10.
BellerEMvan DrielMLMcGregorL, et alPalliative pharmacological sedation for terminally ill adults. Cochrane Database Syst Rev2015; 1(1): CD010206.
11.
RobijnLDeliensLScherrensAL, et alA systematic review of quality improvement initiatives for continuous sedation until death. Palliat Med2021; 35(4): 670–682.
12.
RietjensJAvan DeldenJJvan der HeideA. Palliative sedation: the end of heated debate?Palliat Med2018; 32(11): 1639–1640.
13.
LevacDColquhounHO’BrienKK. Scoping studies: advancing the methodology. Implement Sci2010; 5(1): 69.
14.
TriccoACLillieEZarinW, et alPRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med2018; 169(7): 467–473.
15.
PollockDPetersMDJKhalilH, et alRecommendations for the extraction, analysis, and presentation of results in scoping reviews. JBI Evid Synth2023; 21(3): 520–532.
16.
ChernyNIRadbruchL. European Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care. Palliat Med2009; 23(7): 581–593.
Veldwijk-RouwenhorstAESmalbruggeMZuidemaSU, et alContinuous palliative sedation in nursing home residents with dementia and refractory neuropsychiatric symptoms. J Am Med Dir Assoc2021; 22(2): 305–311.e4.
20.
MaréchalNSixSClemmenE, et alReporting of palliative sedation and use of opioids at the end of life in a Belgian University Hospital: a pilot study. J Palliat Med2022; 25(5): 742–748.
21.
Korzeniewska-EksterowiczAPrzysło FendlerW, et alPalliative sedation at home for terminally ill children with cancer. J Pain Symptom Manag2014; 48(5): 968–974.
22.
Benitez-RosarioMACastillo-PadrósMGarrido-BernetB, et alQuality of care in palliative sedation: audit and compliance monitoring of a clinical protocol. J Pain Symptom Manag2012; 44(4): 532–541.
23.
VieilleMDanyLCozPL, et alPerception, beliefs, and attitudes regarding sedation practices among palliative care nurses and physicians: a qualitative study. Palliat -med Rep2021; 2(1): 160–167.
24.
ChernyNI. ESMO clinical practice guidelines for the management of refractory symptoms at the end of life and the use of palliative sedation. Ann Oncol2014; 25Suppl 3: iii143–iii152.
25.
VivatBBemand-QureshiLHarringtonJ, et alPalliative care specialists in hospice and hospital/community teams predominantly use low doses of sedative medication at the end of life for patient comfort rather than sedation: findings from focus groups and patient records for I-CAN-CARE. Palliat Med2019; 33(6): 578–588.
26.
FredheimOMMaterstvedtLJSkulbergI, et alOught the level of sedation to be reduced during deep palliative sedation? A clinical and ethical analysis. BMJ Support Palliat Care2021; 13(e3): e984–e989.
27.
SurgesSMGarraldaEJaspersB, et alReview of European guidelines on palliative sedation: a foundation for the updating of the European Association for Palliative Care Framework. J Palliat Med2022; 25(11): 1721–1731.
28.
Rodriguez-MirandaRSwetzKMHernández-OrtizA, et alPalliative sedation: clinical practice challenges in Mexico and development of a national protocol for Mexico. Prog Palliat Care2015; 23: 274–280.
29.
RysSDeschepperRMortierF, et alContinuous sedation until death in flemish nursing homes: Justifications and objections of physicians and nurses, Palliative Medicine, p. 627. https://www.embase.com/records?subaction=viewrecord&id=L71176720 (2012, accessed 5 October 2023).
30.
AlessiaSMatildeSFChrystelI, et alThe quality of palliative sedation in end-stage disease: audit from a department of oncology and haematology. Support Care Cancer2022; 30(5): 3849–3855.
31.
RobijnLChambaereKRausK, et alReasons for continuous sedation until death in cancer patients: a qualitative interview study. Eur J Cancer Care2017; 26(1): e12405.
32.
ImaiKMoritaTMoriM, et alFamily experience of palliative sedation therapy: proportional vs. Continuous deep sedation. Support Care Cancer2022; 30(5): 3903–3915.
33.
SwartS. The practice of palliative sedation in the Netherlands after the launch of the national guideline [Internet]. https://repub.eur.nl/pub/40317 (2013, accessed 5 October 2023).
34.
Petre-CiudinVPetre-CiudinCVelnicAA, et alPalliative sedation in controlling the refractory symptoms in oncologic patients. A bioethical approach. Archives of the Balkan Medical Union2017; 52: 434–438.
35.
CockerASingyPJoxRJ. How should health care providers inform about palliative sedation? A qualitative study with palliative care professionals. Eur J Cancer Care2022; 31(5): e13602.
36.
GonçalvesFCorderoAAlmeidaA, et alA survey of the sedation practice of Portuguese palliative care teams. Support Care Cancer2012; 20(12): 3123–3127.
37.
HedmanCRossoAHäggströmO, et alSedation in specialized palliative care: a cross-sectional study. PLOS ONE2022; 17(7): e0270483.
38.
BrueraE. Palliative sedation: when and how?JCO2012; 30(12): 1258–1259.
39.
EunYHongIWBrueraE, et alQualitative study on the perceptions of terminally ill cancer patients and their family members regarding end-of-life experiences focusing on palliative sedation. J Pain Symptom Manag2017; 53(6): 1010–1016.
40.
van DoorenSvan VeluwHTvan ZuylenL, et alExploration of concerns of relatives during continuous palliative sedation of their family members with cancer. J Pain Symptom Manag2009; 38(3): 452–459.
41.
TursunovOChernyNGanzF. Experiences of family members of dying patients receiving palliative sedation. ONF2016; 43(6): E226–E232.
42.
KwonSKimMChoiS. Ethical dilemmas and care actions in nurses providing palliative sedation. Nurs Ethics2022; 29(5): 1220–1230.
43.
BruinsmaSMBrownJvan der HeideA, et alMaking sense of continuous sedation in end-of-life care for cancer patients: an interview study with bereaved relatives in three European countries. Support Care Cancer2014; 22(12): 3243–3252.
44.
HwangIC. Current status and future directions of research on palliative sedation. Korean J Hosp Palliat Care2022; 25(4): 193–197.
45.
CotogniPBrazziL. Palliative sedation: a feasible option to improve end-of-life care in seriously ill dying patients. Minerva Anestesiol2017; 83(5): 446–448.
46.
KirkTWMahonMM. National Hospice and Palliative Care Organization (NHPCO) position statement and commentary on the use of palliative sedation in imminently dying terminally ill patients. J Pain Symptom Manag2010; 39(5): 914–923.
47.
RobijnLGijsbertsMJPypeP, et alContinuous palliative sedation until death: the development of a practice protocol for nursing homes. J Am Med Dir Assoc2021; 22(8): 1776.e1–1776.e7.
48.
HamanoJMoritaTMoriM, et alTalking about palliative sedation with the family: informed consent vs. Assent and a better framework for explaining potential risks. J Pain Symptom Manag2018; 56(3): e5–e8.
49.
Ramos-RinconJMMoreno-PerezOGomez-MartinezN, et alPalliative sedation in COVID-19 end-of-life care. Retrospective cohort study. Medicinar2021; 57(9): 873.
SixSVan OvermeireRBilsenJ, et alAttitudes of professional caregivers and family members regarding the use of monitoring devices to improve assessments of pain and discomfort during continuous sedation until death. J Pain Symptom Manag2020; 60(2): 390–399.
InghelbrechtEBilsenJMortierF, et alContinuous deep sedation until death in Belgium: a survey among nurses. J Pain Symptom Manag2011; 41(5): 870–879.
55.
PradoBLGomesDBDUsón JúniorPLS, et alContinuous palliative sedation for patients with advanced cancer at a tertiary care cancer center. BMC Palliat Care2018; 17(1): 13.
56.
van TolDGKouwenhovenPvan der VegtB, et alDutch physicians on the role of the family in continuous sedation. J Med Ethics2015; 41(3): 240–244.
57.
MeestersSBazataJHandtkeV, et al“It’s pretty much flying blind in the home care setting”: a qualitative study on the influence of home care specific circumstances on sedation in specialist palliative home care. Palliat Med2023; 37(1): 140–148.
58.
MercadanteSPorzioGValleA, et alPalliative sedation in patients with advanced cancer followed at home: a prospective study. J Pain Symptom Manag2014; 47(5): 860–866.
PypePTeuwenIMertensF, et alSuboptimal palliative sedation in primary care: an exploration. Acta Clin Belg2018; 73(1): 21–28.
61.
BergerJT. The limits of surrogates’ moral authority and physician professionalism: can the paradigm of palliative sedation be instructive?Hastings Cent Rep2017; 47(1): 20–23.
62.
BrinkkemperT. Palliative Sedation in the Netherlands: current practice and evaluation of tools for assessing depth of sedation. PhD-Thesis - Research and graduation internal, 2013.
63.
RijpstraMVissersKCentenoC, et alMonitoring the clinical practice of palliative sedation (PALSED) in patients with advanced cancer: an international, multicentre, non-experimental prospective observational study protocol. BMC Palliat Care2023; 22(1): 8.
64.
BuchholdBJülichAGlöcknerF, et alComparison of inpatient and outpatient palliative sedation practice – a prospective observational study. Palliat Support Care2022; 22(4): 1–7.
65.
KoikeKTeruiTIshitaniK. Appropriate symptom management for terminally ill cancer patients lead to decreasing of prevalence of continuous-deep palliative sedation (CDS) Support Care in Cancer 2012; 20: 86. https://www.embase.com/records?subaction=viewrecord&id=L71310617 (accessed 3 July 2025).
66.
PartainDKZehmA. Palliative sedation therapy for terminal movement disorders. BMJ Support Palliat Care2020; 13(e1): e96–e98.
67.
CuvielloAJohnsonLMAnghelescuD, et alA case-based approach to palliative sedation therapy (PST). J Pain Symptom Manage2023; 65(3):e291–e292.
68.
McKinnonMAzevedoCBushSH, et alPractice and documentation of palliative sedation: a quality improvement initiative. Curr Oncol2014; 21(2): 100–103.
69.
PawsonRGreenhalghTHarveyG, et alRealist review- a new method of systematic review designed for complex policy interventions. J Health Serv Res Policy2005; 10: 21–34.
70.
BenziesKMPremjiSHaydenKA, et alState-of-the-evidence reviews: advantages and challenges of including grey literature. Worldviews Evid Based Nurs2006; 3(2): 55–61.
71.
HopewellSMcDonaldSClarkeM, et alGrey literature in meta-analyses of randomized trials of health care interventions. Cochrane Database Syst Rev2007; 2007(2): MR000010.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
